Though revenue growth for BOS continued to outperform the underlying industry volume trends, revenue/EBITDA missed our estimate due to weakness in the Power Tool business. We expect this outperformance to continue on account of a CV cycle revival, higher content, and increase in exports. However, a margin recovery is still awaited. Since the CMP reflects all negatives, we see no major re-rating catalysts on the anvil. We reduce our FY22E/FY23E EPS by 9%/3% to account for lower revenue...